Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F1AX
|
|||
| Former ID |
DIB002105
|
|||
| Drug Name |
CB-102930
|
|||
| Synonyms |
Antimicrobials, Cubist; CB-193; CB-286; CB-432; CB-447; CB-454; CB-484; CB-545; CB-628; CB-629; TRNA synthetase inhibitors (antimicrobial); TRNA synthetase inhibitors (antimicrobial), Cubist
Click to Show/Hide
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Terminated | [1] | |
| Company |
Cubist Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fungal Isoleucyl t-RNA synthetase (Fung ILS1) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016793) | |||
| REF 2 | Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents. Antimicrob Agents Chemother. 2005 December; 49(12): 4821-4833. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.